A new once-daily cystic fibrosis (CF) treatment trialled in Manchester has been approved for NHS use, following a recommendation made earlier this month by the National Institute for Health ...

Research and Innovation We work with patients, universities, industry and others to take the best new ideas from cutting-edge science, and use them to create new tests and treatments that benefit ...

Through our pioneering research and innovation we are improving lives by giving patients the opportunity to shape and take part in clinical studies and evaluations. Click the image below to view our ...

As part of a wider World Health Organisation goal to eliminate hepatitis C (a virus that can infect the liver), globally by 2030, NHS England is committed to eliminating hepatitis C by 2025. About the ...

A ground-breaking genetic test that could prevent critically ill newborn babies going deaf if treated with gentamicin, a commonly used antibiotic, is being trialled across 14 NHS neonatal (specialist ...

Award winning Dr Fozia Ahmed is a Consultant Cardiologist at Manchester University NHS Foundation Trust (MFT). She is also the national lead and co-chair of the Global Expert Panel for STEP HFpEF – a ...

Researchers at Manchester University NHS Foundation Trust (MFT) are recruiting people to take part in a clinical trial to see if an investigational vaccine (a vaccine that is being studied) may be ...

New research from Manchester University NHS Foundation Trust (MFT) and co-funded by the National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre (BRC), has shown ...

North Manchester General Hospital (NMGH) is located in Crumpsall, 3.5 miles north of Manchester City Centre and is now part of the wider family of MFT hospitals creating a Single Hospital ...

The Research and Innovation (R&I) Annual Report for 2023 – 2024: Delivering Change Together (covering 1 April 2023 to 31 March 2024) details the scope and breadth of R&I at Manchester University NHS ...

Babies and toddlers with a rare and fatal genetic condition can now receive life-saving treatment on the NHS for the first time. This follows clinical research studies first carried out at the ...